Designates last full week of September of each year as "Frontotemporal Degeneration Awareness Week" in NJ.
The resolution aims to address the significant lack of awareness surrounding FTD, which is often misdiagnosed and overlooked in comparison to more common forms of dementia such as Alzheimer's disease. By establishing an awareness week, SJR142 encourages public events and discussions to highlight the impact of FTD on individuals and families in New Jersey. This focus could potentially lead to increased funding for research and support services tailored specifically for those affected by FTD, aiding both patients and caregivers in better understanding and navigating the challenges associated with the disease.
SJR142 is a Senate Joint Resolution introduced in New Jersey that designates the last full week of September each year as 'Frontotemporal Degeneration Awareness Week.' This initiative aims to raise awareness about Frontotemporal Dementia (FTD), a group of disorders characterized by progressive nerve cell loss in the brain, specifically affecting the frontal and temporal lobes. FTD is noted for being a terminal and incurable neurodegenerative disease, leading to significant impairments in speech, personality, behavior, and motor skills. It predominantly affects individuals under 60, making it crucial for fostering public awareness regarding this condition.
One notable point within the resolution is the emphasis it places on the social implications of FTD. The bill underscores the frequent misdiagnosis of this condition as psychiatric disorders or other neurodegenerative diseases, which can hinder appropriate treatment and support for those affected. Furthermore, the high rate of individuals living with a family history of FTD raises concerns about genetic predispositions that warrant further research and public inquiry. By officially recognizing September as an awareness month, the resolution seeks to change the conversation about FTD and promote understanding within the wider community.